autoimmune disease

Nkarta’s cell therapy for lupus approved by FDA

Nkarta’s breakthrough cell therapy for lupus gets FDA approval after showing promise in cancer treatment

Anika Sharma

In a groundbreaking development, Nkarta is pushing the boundaries of cell therapy beyond the realm of cancer. The FDA has ...

Breakthrough Discovery Unveils New Mechanism Behind Autoimmune Diseases, Shedding Light on B Cell Self-Reactivity

Breakthrough Discovery Unveils New Mechanism Behind Autoimmune Diseases, Shedding Light on B Cell Self-Reactivity

Anika Sharma

In a groundbreaking revelation, scientists have uncovered a vital piece of the puzzle that elucidates the perplexing phenomenon of B ...

Roivant’s IMVT-1402 lowers IgG without cholesterol or albumin issues, boosting CEO Gline’s debut

Roivant’s IMVT-1402 lowers IgG without cholesterol or albumin issues, boosting CEO Gline’s debut

Anika Sharma

Roivant CEO Matt Gline faced an immediate challenge in 2021 when he took the helm, discovering that Immunovant’s lead asset ...

Inventiva Hepalys Pharma NASH deal, Kezar Everest Medicines lupus deal, Lanifibranor NASH Japan South Korea, Zetomipzomib lupus nephritis China, Inventiva Kezar Asian milestones and royalties, NASH and lupus nephritis treatments, Hepalys Pharma and Everest Medicines biotechs,

Inventiva and Kezar partner with Asian biotechs to advance NASH and lupus drugs

Anika Sharma

In a strategic move, Inventiva and Kezar Life Sciences have successfully secured buyers for the Asian rights to their lead ...

Bristol Myers Squibb, Zenas BioPharma, Xencor, autoimmune disease

BMS acquires regional rights to Zenas’ obexelimab, a bifunctional antibody for autoimmune diseases

Anika Sharma

Zenas BioPharma has made a strategic move by transferring regional rights for its bifunctional monoclonal antibody, obexelimab. Bristol Myers Squibb ...